Results 221 to 230 of about 415,670 (364)

Synthesis and optimization of niosomal carriers containing doxorubicin in order to achieve a final formulation with high potential in cancer cells temperature and acidity

Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2019
Introdution: Doxorubicin is one of the most commonly used drugs in chemotherapy with many side effects; this fact has limited its use. In the present study, based on the knowledge of pharmaceutical nanocarriers, various formulations of the niosomal form ...
Hashem Shahi Malmir, Seyed Mehdi Kalantar, Elham Sasani, Morteza Asgari, Mohammad Majdizadeh, Bibi Fatemeh Haghiralsadat   +5 more
doaj  

Biocompatible Glycol Chitosan Microgels as Effective Drug Carriers. [PDF]

Gels, 2023
Sahiner M, Yilmaz AS, Ayyala RS, Sahiner N.   +3 more
europepmc   +1 more source

Poly(ethylene oxide)-b-poly(N-isopropylacrylamide) nanoparticles with cross-linked cores as drug carriers [PDF]

, 2005
Yi Zeng, William G. Pitt
openalex   +1 more source

New magnetic drug carrier

Journal of Pharmacy and Pharmacology, 1983
Patrick Couvreur, Peter Speiser, Marie Roland, A. Ibrahim   +3 more
openaire   +3 more sources

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Nanogels-Innovative Drug Carriers for Overcoming Biological Membranes. [PDF]

Gels
Radeva L, Yoncheva K.
europepmc   +1 more source

Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment. [PDF]

Materials (Basel), 2023
Abdel-Mottaleb MMA, Boi L, Barra M, Colin J, Berni L, Béduneau A, Moulari B, Pellequer Y.   +7 more
europepmc   +1 more source

Drug-Squeezing Effect in Tablets with .KAPPA.-Carrageenan and Methyl Glycol Chitosan as Drug Carriers.

, 2001
Shintarou KANBAYASHI
openalex   +2 more sources

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Development of particulate drug carriers based on the analysis of important determinants in their disposition.

, 2001
Ken‐ichi Ogawara, Kazutaka Higaki, Toshikiro Kimura   +2 more
openalex   +2 more sources